Ποια είναι η τιμή για Acura Pharmaceuticals, Inc. (ACUR)

Η τιμή για Acura Pharmaceuticals, Inc. (ACUR) είναι $0.0001

Ποια είναι η κεφαλαιοποίηση αγοράς για Acura Pharmaceuticals, Inc. (ACUR)

Η κεφαλαιοποίηση αγοράς για Acura Pharmaceuticals, Inc. (ACUR) είναι $6.60K

Acura Pharmaceuticals, Inc. (ACUR) Τιμή και Κεφαλαιοποίηση Αγοράς

Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals maintains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.

Η τιμή για ACUR	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$81,566.05 $6.60K	NVDA	$5.383T	+81,566,052,324.24%
$67,021.08 $6.60K	AAPL	$4.423T	+67,021,078,744.52%
$63,035.90 $6.60K	GOOG	$4.160T	+63,035,899,886.09%
$55,504.86 $6.60K	MSFT	$3.663T	+55,504,861,066.67%
$43,806.50 $6.60K	AMZN	$2.891T	+43,806,496,800.00%

Η τιμή για ACUR

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$81,566.05 $6.60K